BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33727012)

  • 1. Performance evaluation of the fully automated molecular system Alinity m in a high-throughput central laboratory.
    Galindo LT; Hristov AD; Gentil LG; Scarpelli L; Santiago J; Levi JE
    J Clin Virol; 2021 Apr; 137():104786. PubMed ID: 33727012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Abbott Alinity m and m2000 assays for the quantification of HIV-1, HCV and HBV in clinical samples.
    Mouna L; Pallier C; Proust S; Prégermain C; Roque-Afonso AM
    J Clin Virol; 2020 May; 126():104331. PubMed ID: 32179444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter clinical comparative evaluation of Alinity m HIV-1 assay performance.
    Braun P; Glass A; Maree L; Krügel M; Pacenti M; Onelia F; Gunson R; Goldstein E; Martínez-García L; Galán JC; Vilas A; D'costa J; Sameer R; Ehret R; Knechten H; Naeth G; Bouvier-Alias M; Marlowe N; Palm MJ; Joseph AM; Dhein J; Reinhardt B; Pfeifer K; Lucic D; Obermeier M
    J Clin Virol; 2020 Aug; 129():104530. PubMed ID: 32688329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Alinity m HIV-1 assay for the quantification of HIV-1 RNA plasma viral load in a high-throughput molecular laboratory in South Africa.
    Maree L; Krügel M; Reinhardt B; Glass AJ
    J Clin Virol; 2020 Nov; 132():104644. PubMed ID: 32992087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter clinical evaluation of alinity m HBV assay performance.
    Bonanzinga S; Onelia F; Jackson K; Glass A; Maree L; Krügel M; Pacenti M; Gunson R; Goldstein E; García LM; Galán JC; Vilas A; Ehret R; Knechten H; Naeth G; Braun P; Obermeier M; Marlowe N; Palm MJ; Pfeifer K; Joseph AM; Dhein J; Reinhardt B; Lucic D; Chevaliez S
    J Clin Virol; 2020 Aug; 129():104514. PubMed ID: 32688328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter clinical evaluation of alinity m HCV assay performance.
    Chevaliez S; Onelia F; Pacenti M; Goldstein E; Galán JC; Martínez-García L; Vilas A; Glass A; Maree L; Krügel M; Ehret R; Knechten H; Braun P; Naeth G; Bonanzinga S; Jackson K; Abravaya K; Dhein J; Huang S; Joseph AM; Lucic D; Marlowe N; Palm MJ; Pfeifer K; Toolsie D; Reinhardt B; Obermeier M; Gunson R
    J Clin Virol; 2020 Aug; 129():104531. PubMed ID: 32688330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter performance evaluation of the Alinity m CMV assay for quantifying cytomegalovirus DNA in plasma samples.
    Lee M; Albert E; Wessels E; Kim S-K; Chung H-S; Giménez E; Vreeswijk T; Claas ECJ; Tai YC; Reinhardt B; Sasaki MM; Navarro D
    J Clin Microbiol; 2023 Oct; 61(10):e0041523. PubMed ID: 37728341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the aptima HIV-1 quant Dx, HCV quant Dx and HBV quant assays against the Abbott HIV-1, HCV and HBV RealTime assays.
    May S; Adamska E; Tang JW
    J Clin Virol; 2018 Sep; 106():7-10. PubMed ID: 30007139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical performance of two new, fully integrated molecular platforms used for HIV-1, HBV and HCV viral load analysis, the NeuMoDx 288 and the Alinity m.
    Mourik K; Boers SA; van Rijn AL; Thijssen JCP; Wessels E; Claas ECJ
    J Clin Virol; 2023 Mar; 160():105376. PubMed ID: 36640531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating utilising the Alinity m platform to detect hepatitis C virus RNA in dried blood spot samples.
    Goldstein EJ; Shepherd SJ; Gunson RN
    J Clin Virol; 2020 Nov; 132():104647. PubMed ID: 32979769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verification and Validation of SARS-CoV-2 Assay Performance on the Abbott
    Hirschhorn JW; Kegl A; Dickerson T; Glen WB; Xu G; Alden J; Nolte FS
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33568468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-site performance evaluation of the Alinity m Molecular assay for quantifying Epstein-Barr virus DNA in plasma samples.
    Wessels E; Albert E; Vreeswijk T; Claas ECJ; Giménez E; Reinhardt B; Sasaki MM; Navarro D
    J Clin Microbiol; 2023 Oct; 61(10):e0047223. PubMed ID: 37728343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in-house assay for BK polyomavirus quantification using the Abbott m2000 RealTime system.
    Muldrew KL; Lovett JL
    J Med Microbiol; 2013 Nov; 62(Pt 11):1714-1720. PubMed ID: 23924663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of the automated Abbott RealTime SARS-CoV-2, Alinity m SARS-CoV-2, and Alinity m Resp-4-Plex assays.
    Ehret R; Breuer S; Dhein J; Reinhardt B; Obermeier M
    J Virol Methods; 2022 Jan; 299():114338. PubMed ID: 34695479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Performance Characteristics of the Aptima HIV-1 Quant Dx Assay for Detection and Quantitation of Human Immunodeficiency Virus Type 1 in Plasma and Cervicovaginal Lavage Samples.
    Sam SS; Kurpewski JR; Cu-Uvin S; Caliendo AM
    J Clin Microbiol; 2016 Apr; 54(4):1036-41. PubMed ID: 26842702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving clinical laboratory efficiency: a time-motion evaluation of the Abbott m2000 RealTime and Roche COBAS AmpliPrep/COBAS TaqMan PCR systems for the simultaneous quantitation of HIV-1 RNA and HCV RNA.
    Amendola A; Coen S; Belladonna S; Pulvirenti FR; Clemens JM; Capobianchi MR
    Clin Chem Lab Med; 2011 Aug; 49(8):1283-1288. PubMed ID: 21619477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance assessment of the new Xpert® HIV-1 viral load XC assay for quantification of HIV-1 viral loads.
    Ehret R; Harb K; Breuer S; Obermeier M
    J Clin Virol; 2022 Apr; 149():105127. PubMed ID: 35305378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance evaluation of the QIAGEN EZ1 DSP Virus Kit with Abbott RealTime HIV-1, HBV and HCV assays.
    Schneider GJ; Kuper KG; Abravaya K; Mullen CR; Schmidt M; Bunse-Grassmann A; Sprenger-Haussels M
    J Clin Virol; 2009 Apr; 44(4):292-6. PubMed ID: 19286419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of dried blood spot testing using the Abbott Alinity i.
    Shepherd SJ; McLellan H; Bell J; Gunson RN
    J Clin Virol; 2020 Nov; 132():104638. PubMed ID: 33049642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the New Abbott mPLUS feature on clinical laboratory efficiencies of abbott RealTime assays for detection of HIV-1, Hepatitis C Virus, Hepatitis B Virus, Chlamydia trachomatis, and Neisseria gonorrhoeae.
    Lucic D; Jones S; Wiesneth R; Barry C; Webb E; Belova L; Dolan P; Ho S; Abravaya K; Cloherty G
    J Clin Microbiol; 2013 Dec; 51(12):4050-4. PubMed ID: 24088850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.